| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chemokines | 60 | 2021 | 968 | 8.780 |
Why?
|
| Receptors, CXCR3 | 57 | 2021 | 237 | 6.140 |
Why?
|
| Receptors, Chemokine | 54 | 2019 | 670 | 5.810 |
Why?
|
| Chemokines, CXC | 64 | 2012 | 422 | 5.430 |
Why?
|
| Chemokine CXCL10 | 76 | 2021 | 305 | 4.970 |
Why?
|
| Chemotaxis, Leukocyte | 37 | 2017 | 675 | 4.650 |
Why?
|
| Cell Movement | 63 | 2021 | 5216 | 3.410 |
Why?
|
| Receptors, Leukotriene B4 | 23 | 2017 | 94 | 3.320 |
Why?
|
| Neutrophils | 30 | 2020 | 3718 | 2.970 |
Why?
|
| Chemokines, CC | 34 | 2013 | 290 | 2.860 |
Why?
|
| Th2 Cells | 19 | 2020 | 1061 | 2.800 |
Why?
|
| Leukotriene B4 | 21 | 2018 | 294 | 2.670 |
Why?
|
| T-Lymphocytes | 49 | 2020 | 10179 | 2.530 |
Why?
|
| T-Lymphocyte Subsets | 20 | 2020 | 1837 | 2.370 |
Why?
|
| CD8-Positive T-Lymphocytes | 39 | 2021 | 4477 | 2.110 |
Why?
|
| Hypersensitivity | 16 | 2023 | 1102 | 2.110 |
Why?
|
| Th1 Cells | 13 | 2021 | 1057 | 1.850 |
Why?
|
| Immunologic Memory | 15 | 2020 | 1347 | 1.830 |
Why?
|
| Immunity | 8 | 2021 | 1013 | 1.820 |
Why?
|
| Inflammation | 49 | 2023 | 10629 | 1.800 |
Why?
|
| Receptor, Anaphylatoxin C5a | 3 | 2019 | 90 | 1.710 |
Why?
|
| Chemokine CXCL9 | 29 | 2020 | 132 | 1.700 |
Why?
|
| Monocytes | 23 | 2021 | 2593 | 1.690 |
Why?
|
| CD4-Positive T-Lymphocytes | 31 | 2024 | 4386 | 1.670 |
Why?
|
| Arthritis, Experimental | 7 | 2016 | 291 | 1.660 |
Why?
|
| Receptors, CCR7 | 7 | 2018 | 108 | 1.660 |
Why?
|
| Neutrophil Infiltration | 7 | 2020 | 390 | 1.630 |
Why?
|
| Asthma | 31 | 2023 | 6010 | 1.560 |
Why?
|
| Lymph Nodes | 20 | 2021 | 3476 | 1.540 |
Why?
|
| Mice | 202 | 2024 | 81154 | 1.520 |
Why?
|
| Allergens | 18 | 2023 | 1320 | 1.500 |
Why?
|
| Eosinophils | 26 | 2013 | 954 | 1.500 |
Why?
|
| Animals | 249 | 2024 | 168660 | 1.490 |
Why?
|
| Dendritic Cells | 21 | 2021 | 2720 | 1.490 |
Why?
|
| Receptors, CCR8 | 3 | 2018 | 27 | 1.470 |
Why?
|
| Monocyte Chemoattractant Proteins | 13 | 2004 | 48 | 1.430 |
Why?
|
| Mice, Knockout | 85 | 2021 | 14563 | 1.430 |
Why?
|
| Interferon-gamma | 45 | 2021 | 3205 | 1.420 |
Why?
|
| Complement C5a | 3 | 2019 | 107 | 1.390 |
Why?
|
| Mice, Inbred C57BL | 99 | 2021 | 21824 | 1.390 |
Why?
|
| Cytokines | 62 | 2020 | 7324 | 1.350 |
Why?
|
| Immunomodulation | 4 | 2022 | 541 | 1.330 |
Why?
|
| Receptors, CCR4 | 6 | 2016 | 81 | 1.280 |
Why?
|
| Receptors, CCR5 | 17 | 2016 | 498 | 1.270 |
Why?
|
| Chemokine CCL2 | 11 | 2019 | 620 | 1.250 |
Why?
|
| Arthritis | 4 | 2019 | 661 | 1.230 |
Why?
|
| Immunity, Innate | 21 | 2023 | 2961 | 1.220 |
Why?
|
| Lung | 32 | 2020 | 9858 | 1.200 |
Why?
|
| Lymphoid Tissue | 9 | 2019 | 454 | 1.160 |
Why?
|
| Disease Models, Animal | 49 | 2022 | 18027 | 1.140 |
Why?
|
| Malaria, Cerebral | 4 | 2019 | 135 | 1.140 |
Why?
|
| T-Lymphocytes, Regulatory | 11 | 2023 | 2988 | 1.120 |
Why?
|
| Chemotaxis | 16 | 2013 | 607 | 1.100 |
Why?
|
| Receptors, CCR2 | 11 | 2020 | 212 | 1.070 |
Why?
|
| Respiratory Hypersensitivity | 7 | 2019 | 273 | 1.040 |
Why?
|
| Bronchoalveolar Lavage Fluid | 20 | 2013 | 768 | 0.970 |
Why?
|
| Receptors, Purinergic P2 | 7 | 2006 | 153 | 0.960 |
Why?
|
| HIV-1 | 19 | 2019 | 6939 | 0.940 |
Why?
|
| Signal Transduction | 39 | 2021 | 23398 | 0.910 |
Why?
|
| Lymphocytic Choriomeningitis | 3 | 2021 | 132 | 0.890 |
Why?
|
| Chemotactic Factors, Eosinophil | 14 | 2001 | 42 | 0.880 |
Why?
|
| Receptors, Lysosphingolipid | 4 | 2017 | 122 | 0.870 |
Why?
|
| Transendothelial and Transepithelial Migration | 2 | 2020 | 102 | 0.870 |
Why?
|
| Leukocytes | 13 | 2020 | 2044 | 0.870 |
Why?
|
| Ovalbumin | 17 | 2015 | 719 | 0.860 |
Why?
|
| Adoptive Transfer | 12 | 2016 | 844 | 0.850 |
Why?
|
| Vagina | 5 | 2017 | 825 | 0.830 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 10 | 2004 | 1678 | 0.830 |
Why?
|
| Cell Adhesion | 14 | 2019 | 3144 | 0.820 |
Why?
|
| Receptors, Cytokine | 10 | 2018 | 262 | 0.800 |
Why?
|
| Histamine Antagonists | 1 | 2021 | 93 | 0.790 |
Why?
|
| Lymphocytic choriomeningitis virus | 2 | 2021 | 168 | 0.790 |
Why?
|
| Chemokine CXCL1 | 2 | 2020 | 101 | 0.780 |
Why?
|
| Ligands | 19 | 2021 | 3281 | 0.770 |
Why?
|
| Lymphocyte Activation | 23 | 2021 | 5524 | 0.770 |
Why?
|
| Integrin alpha1 | 1 | 2020 | 13 | 0.760 |
Why?
|
| Spleen | 8 | 2021 | 2359 | 0.760 |
Why?
|
| Histamine | 2 | 2021 | 507 | 0.750 |
Why?
|
| Synaptotagmins | 2 | 2011 | 59 | 0.740 |
Why?
|
| Chemokine CCL8 | 4 | 2018 | 18 | 0.740 |
Why?
|
| Encephalitis, Viral | 1 | 2020 | 55 | 0.730 |
Why?
|
| Antigens | 12 | 2021 | 1466 | 0.720 |
Why?
|
| Endothelial Cells | 9 | 2019 | 3482 | 0.720 |
Why?
|
| Chemokine CXCL11 | 15 | 2009 | 42 | 0.710 |
Why?
|
| Bronchial Hyperreactivity | 9 | 2013 | 319 | 0.710 |
Why?
|
| Graft Rejection | 12 | 2013 | 4398 | 0.690 |
Why?
|
| Receptors, Lysophosphatidic Acid | 4 | 2016 | 76 | 0.650 |
Why?
|
| Chemotactic Factors | 5 | 2015 | 199 | 0.650 |
Why?
|
| Autoimmunity | 5 | 2019 | 1349 | 0.650 |
Why?
|
| Biological Factors | 1 | 2019 | 164 | 0.650 |
Why?
|
| Toll-Like Receptors | 6 | 2010 | 593 | 0.650 |
Why?
|
| Antigen-Presenting Cells | 3 | 2021 | 972 | 0.640 |
Why?
|
| Pulmonary Eosinophilia | 7 | 2011 | 82 | 0.630 |
Why?
|
| Mice, Transgenic | 32 | 2022 | 9731 | 0.630 |
Why?
|
| HIV Infections | 18 | 2019 | 16715 | 0.620 |
Why?
|
| Immunization | 2 | 2020 | 1255 | 0.610 |
Why?
|
| B-Lymphocytes | 8 | 2019 | 4665 | 0.600 |
Why?
|
| Orthomyxoviridae Infections | 5 | 2015 | 247 | 0.590 |
Why?
|
| Arteritis | 1 | 2019 | 159 | 0.590 |
Why?
|
| Killer Cells, Natural | 9 | 2010 | 2131 | 0.580 |
Why?
|
| Lectins, C-Type | 2 | 2020 | 589 | 0.570 |
Why?
|
| Bronchi | 6 | 2007 | 840 | 0.560 |
Why?
|
| Basophils | 4 | 2009 | 389 | 0.560 |
Why?
|
| Receptors, Interleukin-8B | 4 | 2020 | 60 | 0.560 |
Why?
|
| Endothelium, Vascular | 13 | 2017 | 4459 | 0.550 |
Why?
|
| Receptors, IgG | 6 | 2012 | 581 | 0.550 |
Why?
|
| Sphingosine | 4 | 2016 | 306 | 0.550 |
Why?
|
| Chemokine CCL11 | 29 | 2011 | 129 | 0.540 |
Why?
|
| Astrocytes | 2 | 2020 | 1273 | 0.540 |
Why?
|
| Dermatitis, Atopic | 3 | 2013 | 654 | 0.530 |
Why?
|
| Adaptive Immunity | 3 | 2015 | 715 | 0.530 |
Why?
|
| Mice, Inbred NOD | 12 | 2019 | 1876 | 0.530 |
Why?
|
| Cells, Cultured | 41 | 2018 | 19232 | 0.530 |
Why?
|
| Immunotherapy | 6 | 2021 | 4437 | 0.520 |
Why?
|
| Fibroblasts | 10 | 2019 | 4162 | 0.520 |
Why?
|
| Macrophages | 19 | 2019 | 5651 | 0.520 |
Why?
|
| Chemokine CCL1 | 2 | 2014 | 18 | 0.520 |
Why?
|
| Receptors, Cell Surface | 5 | 2019 | 2865 | 0.510 |
Why?
|
| Membrane Glycoproteins | 8 | 2015 | 3769 | 0.510 |
Why?
|
| Microglia | 5 | 2008 | 1267 | 0.510 |
Why?
|
| T-Lymphocytes, Cytotoxic | 7 | 2021 | 1821 | 0.500 |
Why?
|
| Propylene Glycols | 3 | 2013 | 92 | 0.490 |
Why?
|
| Pulmonary Fibrosis | 7 | 2013 | 530 | 0.490 |
Why?
|
| Bronchiolitis Obliterans | 2 | 2006 | 194 | 0.490 |
Why?
|
| Cell Proliferation | 17 | 2021 | 10477 | 0.480 |
Why?
|
| Mice, Inbred BALB C | 23 | 2017 | 6380 | 0.480 |
Why?
|
| Immunophenotyping | 10 | 2022 | 1880 | 0.480 |
Why?
|
| Blood-Brain Barrier | 1 | 2020 | 1018 | 0.480 |
Why?
|
| Genitalia, Female | 1 | 2015 | 146 | 0.470 |
Why?
|
| Influenza, Human | 2 | 2023 | 1480 | 0.470 |
Why?
|
| Herpes Genitalis | 1 | 2015 | 140 | 0.470 |
Why?
|
| Receptors, CXCR4 | 12 | 2017 | 727 | 0.470 |
Why?
|
| Immunization, Passive | 1 | 2016 | 623 | 0.470 |
Why?
|
| Humans | 193 | 2023 | 743811 | 0.460 |
Why?
|
| Herpesvirus 2, Human | 1 | 2015 | 189 | 0.460 |
Why?
|
| STAT6 Transcription Factor | 4 | 2009 | 199 | 0.460 |
Why?
|
| Interleukin-1beta | 4 | 2019 | 973 | 0.460 |
Why?
|
| Down-Regulation | 7 | 2010 | 3000 | 0.450 |
Why?
|
| Pneumonia | 6 | 2020 | 2133 | 0.450 |
Why?
|
| Chlamydia trachomatis | 1 | 2015 | 246 | 0.450 |
Why?
|
| Receptors, Lymphocyte Homing | 4 | 2012 | 143 | 0.440 |
Why?
|
| Rheumatic Diseases | 1 | 2019 | 593 | 0.440 |
Why?
|
| Mucus | 5 | 2020 | 321 | 0.440 |
Why?
|
| Models, Immunological | 6 | 2012 | 527 | 0.440 |
Why?
|
| Interleukin-4 | 7 | 2013 | 1147 | 0.440 |
Why?
|
| Lung Injury | 4 | 2013 | 432 | 0.430 |
Why?
|
| STAT1 Transcription Factor | 4 | 2015 | 320 | 0.420 |
Why?
|
| Lysophospholipids | 5 | 2016 | 330 | 0.420 |
Why?
|
| Lung Transplantation | 3 | 2013 | 1155 | 0.420 |
Why?
|
| Mice, SCID | 12 | 2017 | 2718 | 0.410 |
Why?
|
| Neoplasms | 7 | 2021 | 21675 | 0.410 |
Why?
|
| Immunity, Cellular | 6 | 2016 | 1608 | 0.410 |
Why?
|
| Toxoplasma | 5 | 2012 | 149 | 0.400 |
Why?
|
| Interleukin-23 | 1 | 2013 | 194 | 0.400 |
Why?
|
| Receptors, Interleukin-17 | 1 | 2011 | 69 | 0.400 |
Why?
|
| Chlamydia Infections | 1 | 2015 | 365 | 0.390 |
Why?
|
| Epithelium | 5 | 2013 | 1679 | 0.390 |
Why?
|
| Aminoacyltransferases | 1 | 2011 | 51 | 0.390 |
Why?
|
| Natural Killer T-Cells | 3 | 2011 | 316 | 0.380 |
Why?
|
| Epitopes, T-Lymphocyte | 6 | 2024 | 880 | 0.370 |
Why?
|
| Gene Expression Regulation | 26 | 2016 | 12066 | 0.370 |
Why?
|
| Skin | 12 | 2021 | 4372 | 0.370 |
Why?
|
| Inflammation Mediators | 7 | 2015 | 1888 | 0.370 |
Why?
|
| Antibodies, Neutralizing | 3 | 2017 | 1978 | 0.370 |
Why?
|
| Interleukin-1alpha | 1 | 2010 | 85 | 0.360 |
Why?
|
| HIV Antibodies | 3 | 2016 | 1322 | 0.360 |
Why?
|
| Virus Replication | 9 | 2016 | 2535 | 0.360 |
Why?
|
| Calcium | 19 | 2018 | 5755 | 0.360 |
Why?
|
| Arteriosclerosis | 4 | 2007 | 1092 | 0.360 |
Why?
|
| Lupus Erythematosus, Systemic | 4 | 2022 | 2104 | 0.360 |
Why?
|
| Islets of Langerhans Transplantation | 3 | 2004 | 745 | 0.350 |
Why?
|
| Antirheumatic Agents | 1 | 2019 | 1338 | 0.350 |
Why?
|
| Molecular Sequence Data | 27 | 2014 | 18107 | 0.350 |
Why?
|
| Interleukin-1 | 8 | 2023 | 1263 | 0.340 |
Why?
|
| RNA, Messenger | 40 | 2011 | 13028 | 0.340 |
Why?
|
| Interleukin-8 | 6 | 2016 | 690 | 0.340 |
Why?
|
| Autoantibodies | 6 | 2022 | 2037 | 0.340 |
Why?
|
| Glycosaminoglycans | 5 | 2017 | 624 | 0.330 |
Why?
|
| Chemokine CCL19 | 3 | 2018 | 35 | 0.330 |
Why?
|
| Toxoplasmosis | 2 | 2006 | 91 | 0.330 |
Why?
|
| Cell Differentiation | 14 | 2021 | 11478 | 0.320 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 4 | 2004 | 834 | 0.320 |
Why?
|
| Scavenger Receptors, Class F | 2 | 2022 | 16 | 0.320 |
Why?
|
| Receptors, Interleukin-8A | 2 | 2005 | 44 | 0.320 |
Why?
|
| Synovial Fluid | 4 | 2018 | 394 | 0.320 |
Why?
|
| Epithelial Cells | 9 | 2016 | 3690 | 0.320 |
Why?
|
| Receptors, Eicosanoid | 1 | 2007 | 12 | 0.310 |
Why?
|
| Disease Transmission, Infectious | 1 | 2013 | 546 | 0.310 |
Why?
|
| Autoimmune Diseases | 3 | 2018 | 2134 | 0.310 |
Why?
|
| Flow Cytometry | 16 | 2016 | 5973 | 0.310 |
Why?
|
| Cell Migration Inhibition | 7 | 2013 | 96 | 0.300 |
Why?
|
| Antibodies | 6 | 2011 | 2459 | 0.300 |
Why?
|
| Organ Specificity | 6 | 2015 | 2008 | 0.300 |
Why?
|
| Antibodies, Blocking | 4 | 2018 | 253 | 0.300 |
Why?
|
| Interleukin-5 | 6 | 2013 | 273 | 0.290 |
Why?
|
| Antigens, CD1 | 3 | 2006 | 437 | 0.290 |
Why?
|
| Tumor Microenvironment | 4 | 2021 | 3583 | 0.290 |
Why?
|
| Endotoxins | 1 | 2009 | 527 | 0.280 |
Why?
|
| Lymphocytes | 7 | 2023 | 2615 | 0.280 |
Why?
|
| Chemokine CXCL12 | 10 | 2017 | 465 | 0.280 |
Why?
|
| Isoenzymes | 1 | 2011 | 1728 | 0.280 |
Why?
|
| Immune System | 2 | 2014 | 807 | 0.280 |
Why?
|
| Amino Acid Sequence | 22 | 2014 | 13809 | 0.280 |
Why?
|
| Neovascularization, Pathologic | 5 | 2014 | 2638 | 0.280 |
Why?
|
| Vaccines | 1 | 2015 | 823 | 0.280 |
Why?
|
| Cell Line | 20 | 2013 | 15993 | 0.270 |
Why?
|
| Lung Diseases | 4 | 2013 | 1887 | 0.270 |
Why?
|
| Recombinant Proteins | 9 | 2006 | 6620 | 0.270 |
Why?
|
| Transplantation Tolerance | 1 | 2011 | 617 | 0.270 |
Why?
|
| Immunohistochemistry | 18 | 2016 | 11360 | 0.270 |
Why?
|
| Mice, Inbred Strains | 11 | 2012 | 1826 | 0.270 |
Why?
|
| Protein Binding | 12 | 2018 | 9377 | 0.270 |
Why?
|
| Plasmodium berghei | 3 | 2019 | 168 | 0.270 |
Why?
|
| Psoriasis | 3 | 2013 | 901 | 0.260 |
Why?
|
| Trachea | 5 | 2006 | 1076 | 0.260 |
Why?
|
| Antigen-Antibody Reactions | 1 | 2005 | 363 | 0.260 |
Why?
|
| Chemokine CCL21 | 3 | 2017 | 51 | 0.260 |
Why?
|
| Neurons | 3 | 2020 | 9336 | 0.250 |
Why?
|
| Interferon-beta | 3 | 2017 | 324 | 0.250 |
Why?
|
| Macrophages, Peritoneal | 2 | 2003 | 251 | 0.250 |
Why?
|
| Phagocytosis | 5 | 2022 | 1539 | 0.250 |
Why?
|
| Bronchial Diseases | 1 | 2005 | 151 | 0.250 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 2 | 2019 | 570 | 0.250 |
Why?
|
| Chemokine CCL5 | 5 | 2000 | 209 | 0.250 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 2 | 2017 | 547 | 0.250 |
Why?
|
| Vitiligo | 2 | 2016 | 89 | 0.240 |
Why?
|
| Cytotoxicity, Immunologic | 4 | 2004 | 1369 | 0.240 |
Why?
|
| Muscle, Smooth | 3 | 2016 | 934 | 0.240 |
Why?
|
| Synovial Membrane | 3 | 2016 | 506 | 0.240 |
Why?
|
| HLA-DR Antigens | 3 | 2005 | 645 | 0.240 |
Why?
|
| Eosinophilia | 5 | 1999 | 541 | 0.240 |
Why?
|
| Bleomycin | 7 | 2011 | 512 | 0.240 |
Why?
|
| Myeloid Cells | 1 | 2009 | 808 | 0.230 |
Why?
|
| Vasculitis | 2 | 2019 | 519 | 0.230 |
Why?
|
| Candida albicans | 3 | 2019 | 394 | 0.230 |
Why?
|
| Up-Regulation | 10 | 2017 | 4221 | 0.230 |
Why?
|
| Cloning, Molecular | 10 | 2011 | 4320 | 0.230 |
Why?
|
| Stromal Cells | 5 | 2018 | 1356 | 0.230 |
Why?
|
| Female | 73 | 2021 | 380020 | 0.230 |
Why?
|
| Granulocytes | 1 | 2005 | 548 | 0.230 |
Why?
|
| Antibodies, Antinuclear | 1 | 2005 | 326 | 0.230 |
Why?
|
| Trans-Activators | 4 | 2016 | 2927 | 0.230 |
Why?
|
| RNA Interference | 2 | 2016 | 2890 | 0.220 |
Why?
|
| Protein Structure, Secondary | 1 | 2006 | 1245 | 0.220 |
Why?
|
| Dose-Response Relationship, Immunologic | 3 | 2016 | 370 | 0.220 |
Why?
|
| Dengue Virus | 3 | 2013 | 204 | 0.220 |
Why?
|
| Antigens, CD1d | 4 | 2010 | 220 | 0.220 |
Why?
|
| Base Sequence | 16 | 2016 | 12798 | 0.220 |
Why?
|
| Transfection | 11 | 2016 | 5892 | 0.220 |
Why?
|
| Arginine | 1 | 2006 | 943 | 0.210 |
Why?
|
| Tyrosine | 2 | 2006 | 1462 | 0.210 |
Why?
|
| Flagellin | 1 | 2003 | 125 | 0.210 |
Why?
|
| Antithrombin III | 1 | 2002 | 128 | 0.210 |
Why?
|
| Macrophage Inflammatory Proteins | 4 | 1998 | 123 | 0.210 |
Why?
|
| Transplantation, Homologous | 8 | 2006 | 4777 | 0.210 |
Why?
|
| Brain | 10 | 2018 | 26345 | 0.210 |
Why?
|
| Immunity, Active | 1 | 2002 | 60 | 0.210 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2023 | 297 | 0.210 |
Why?
|
| Molecular Targeted Therapy | 4 | 2019 | 2727 | 0.210 |
Why?
|
| Alzheimer Disease | 4 | 2008 | 8035 | 0.210 |
Why?
|
| Receptors, CCR1 | 2 | 2012 | 33 | 0.210 |
Why?
|
| Growth Substances | 2 | 2003 | 784 | 0.200 |
Why?
|
| Gene Expression | 12 | 2013 | 7793 | 0.200 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2017 | 3712 | 0.200 |
Why?
|
| Hypertension, Pulmonary | 2 | 2011 | 1534 | 0.200 |
Why?
|
| Dengue | 3 | 2013 | 256 | 0.200 |
Why?
|
| Homeostasis | 4 | 2015 | 3337 | 0.200 |
Why?
|
| Heart Transplantation | 5 | 2004 | 3113 | 0.200 |
Why?
|
| Respiratory System | 3 | 2016 | 557 | 0.200 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2021 | 147 | 0.200 |
Why?
|
| Amyloid beta-Peptides | 5 | 2008 | 3587 | 0.200 |
Why?
|
| Immunoglobulin E | 9 | 2006 | 1463 | 0.190 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 2 | 2013 | 379 | 0.190 |
Why?
|
| Microscopy, Fluorescence | 4 | 2016 | 2692 | 0.190 |
Why?
|
| Receptors, CCR3 | 4 | 2006 | 62 | 0.190 |
Why?
|
| Bone Marrow Cells | 5 | 2016 | 2509 | 0.190 |
Why?
|
| Lymphocyte Subsets | 3 | 2013 | 315 | 0.190 |
Why?
|
| Heart | 2 | 2013 | 4460 | 0.190 |
Why?
|
| Toxoplasmosis, Animal | 1 | 2000 | 17 | 0.190 |
Why?
|
| Lymphocyte Depletion | 3 | 2013 | 608 | 0.190 |
Why?
|
| Heparitin Sulfate | 2 | 2006 | 225 | 0.180 |
Why?
|
| Spores, Fungal | 1 | 2020 | 94 | 0.180 |
Why?
|
| Pyroglyphidae | 1 | 2020 | 88 | 0.180 |
Why?
|
| Heparin | 3 | 2003 | 1637 | 0.180 |
Why?
|
| Disease Susceptibility | 4 | 2022 | 1781 | 0.180 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 9 | 2013 | 3874 | 0.180 |
Why?
|
| Acyclovir | 1 | 2020 | 272 | 0.180 |
Why?
|
| Herpesvirus 1, Human | 2 | 2020 | 743 | 0.170 |
Why?
|
| Receptors, Interferon | 2 | 2018 | 115 | 0.170 |
Why?
|
| RNA, Small Interfering | 6 | 2017 | 3504 | 0.170 |
Why?
|
| Antigens, Ly | 2 | 2017 | 290 | 0.170 |
Why?
|
| Interleukin-12 | 5 | 2021 | 577 | 0.170 |
Why?
|
| DNA, Complementary | 7 | 2004 | 2050 | 0.170 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2005 | 570 | 0.170 |
Why?
|
| Peritonitis | 2 | 2003 | 365 | 0.170 |
Why?
|
| Mutagenesis, Site-Directed | 5 | 2018 | 1723 | 0.170 |
Why?
|
| Antigen Presentation | 4 | 2014 | 1283 | 0.170 |
Why?
|
| Acquired Immunodeficiency Syndrome | 3 | 2016 | 2232 | 0.170 |
Why?
|
| Antibodies, Monoclonal | 11 | 2017 | 9272 | 0.170 |
Why?
|
| Connective Tissue Growth Factor | 2 | 2016 | 96 | 0.170 |
Why?
|
| Antigens, CD | 5 | 2021 | 4026 | 0.170 |
Why?
|
| Fever | 1 | 2006 | 1616 | 0.170 |
Why?
|
| Male | 61 | 2019 | 349776 | 0.170 |
Why?
|
| Duffy Blood-Group System | 1 | 2019 | 58 | 0.170 |
Why?
|
| Receptors, Immunologic | 4 | 2015 | 1423 | 0.170 |
Why?
|
| Receptors, CCR6 | 3 | 2012 | 81 | 0.170 |
Why?
|
| Lymphocyte Count | 5 | 2016 | 793 | 0.160 |
Why?
|
| Multiple Sclerosis | 2 | 2013 | 3079 | 0.160 |
Why?
|
| Receptors, Scavenger | 3 | 2009 | 121 | 0.160 |
Why?
|
| Lyme Disease | 3 | 2010 | 621 | 0.160 |
Why?
|
| Permeability | 1 | 2020 | 738 | 0.160 |
Why?
|
| Melanoma, Experimental | 4 | 2016 | 560 | 0.160 |
Why?
|
| Intercellular Adhesion Molecule-1 | 3 | 2019 | 1159 | 0.160 |
Why?
|
| Aspergillosis | 1 | 2020 | 235 | 0.160 |
Why?
|
| Integrin alpha Chains | 1 | 2018 | 96 | 0.160 |
Why?
|
| Lipopolysaccharides | 5 | 2017 | 2217 | 0.160 |
Why?
|
| Viral Load | 5 | 2013 | 3300 | 0.160 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 2 | 2009 | 89 | 0.160 |
Why?
|
| Epitopes | 2 | 2022 | 2570 | 0.160 |
Why?
|
| Transcriptional Activation | 2 | 2001 | 1783 | 0.150 |
Why?
|
| Airway Remodeling | 1 | 2019 | 132 | 0.150 |
Why?
|
| Adjuvants, Immunologic | 1 | 2003 | 999 | 0.150 |
Why?
|
| Tumor Cells, Cultured | 12 | 2017 | 6311 | 0.150 |
Why?
|
| Epidermis | 3 | 2019 | 529 | 0.150 |
Why?
|
| Interleukins | 3 | 2015 | 791 | 0.150 |
Why?
|
| Paracrine Communication | 1 | 2019 | 278 | 0.150 |
Why?
|
| Immunologic Surveillance | 1 | 2018 | 93 | 0.150 |
Why?
|
| Receptors, OX40 | 1 | 2017 | 43 | 0.150 |
Why?
|
| Cerebellum | 2 | 2002 | 1487 | 0.150 |
Why?
|
| Cell Line, Transformed | 4 | 2006 | 897 | 0.150 |
Why?
|
| Neutrophil Activation | 1 | 2018 | 186 | 0.150 |
Why?
|
| Directed Molecular Evolution | 1 | 2018 | 160 | 0.150 |
Why?
|
| Platelet Factor 4 | 2 | 1995 | 129 | 0.150 |
Why?
|
| Cell Communication | 3 | 2021 | 1621 | 0.150 |
Why?
|
| Platelet Activation | 1 | 2001 | 674 | 0.150 |
Why?
|
| Transcription, Genetic | 10 | 2020 | 7719 | 0.140 |
Why?
|
| Transforming Growth Factor beta | 3 | 2019 | 2006 | 0.140 |
Why?
|
| Orthomyxoviridae | 2 | 2015 | 156 | 0.140 |
Why?
|
| Chemokine CCL24 | 3 | 2013 | 8 | 0.140 |
Why?
|
| Platelet Aggregation | 1 | 2000 | 798 | 0.140 |
Why?
|
| Dexamethasone | 3 | 2000 | 1950 | 0.140 |
Why?
|
| Species Specificity | 5 | 2014 | 2480 | 0.140 |
Why?
|
| Blotting, Western | 6 | 2013 | 5179 | 0.140 |
Why?
|
| Leishmania donovani | 1 | 2016 | 65 | 0.140 |
Why?
|
| Receptors, CCR | 1 | 2016 | 38 | 0.140 |
Why?
|
| Green Fluorescent Proteins | 2 | 2019 | 2086 | 0.140 |
Why?
|
| Drug Delivery Systems | 1 | 2008 | 2217 | 0.140 |
Why?
|
| Cell Lineage | 5 | 2012 | 2506 | 0.140 |
Why?
|
| Gene Knockdown Techniques | 3 | 2016 | 1656 | 0.140 |
Why?
|
| Chemokine CCL22 | 2 | 2009 | 25 | 0.140 |
Why?
|
| Nasal Mucosa | 5 | 2006 | 372 | 0.140 |
Why?
|
| Chemokine CCL17 | 2 | 2009 | 23 | 0.140 |
Why?
|
| Leishmaniasis, Visceral | 1 | 2016 | 94 | 0.130 |
Why?
|
| Lipid Metabolism | 1 | 2004 | 1885 | 0.130 |
Why?
|
| Mononuclear Phagocyte System | 1 | 2015 | 56 | 0.130 |
Why?
|
| CARD Signaling Adaptor Proteins | 3 | 2020 | 156 | 0.130 |
Why?
|
| HIV | 3 | 2016 | 1604 | 0.130 |
Why?
|
| Reperfusion Injury | 3 | 2008 | 1027 | 0.130 |
Why?
|
| Viral Envelope Proteins | 1 | 1999 | 635 | 0.130 |
Why?
|
| Respiratory Mucosa | 3 | 2006 | 427 | 0.130 |
Why?
|
| L-Selectin | 3 | 2008 | 214 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 1997 | 437 | 0.130 |
Why?
|
| Chromosome Mapping | 6 | 1999 | 4737 | 0.130 |
Why?
|
| Tomography, Optical Coherence | 3 | 2019 | 2657 | 0.130 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2000 | 871 | 0.130 |
Why?
|
| Cytoplasmic Granules | 1 | 1998 | 609 | 0.130 |
Why?
|
| Mucous Membrane | 1 | 2019 | 669 | 0.130 |
Why?
|
| Liver | 6 | 2016 | 7479 | 0.130 |
Why?
|
| Terminology as Topic | 2 | 2020 | 1546 | 0.130 |
Why?
|
| Exodeoxyribonucleases | 1 | 2016 | 180 | 0.130 |
Why?
|
| Mast Cells | 3 | 2013 | 1544 | 0.130 |
Why?
|
| Ureteral Obstruction | 1 | 2016 | 296 | 0.120 |
Why?
|
| Protein Synthesis Inhibitors | 3 | 2000 | 192 | 0.120 |
Why?
|
| Myocardial Infarction | 2 | 2013 | 11708 | 0.120 |
Why?
|
| Proteoglycans | 1 | 1998 | 837 | 0.120 |
Why?
|
| Inflammasomes | 1 | 2019 | 496 | 0.120 |
Why?
|
| Adiponectin | 3 | 2011 | 1101 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 1 | 3 | 2017 | 3338 | 0.120 |
Why?
|
| Silicon Dioxide | 1 | 2015 | 213 | 0.120 |
Why?
|
| Leukocyte Count | 4 | 2016 | 1588 | 0.120 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2019 | 546 | 0.120 |
Why?
|
| Biological Transport | 3 | 2011 | 2119 | 0.120 |
Why?
|
| Panniculitis | 1 | 2014 | 45 | 0.120 |
Why?
|
| Bone Marrow | 3 | 2016 | 2951 | 0.120 |
Why?
|
| Virulence Factors, Bordetella | 3 | 2002 | 156 | 0.120 |
Why?
|
| Pertussis Toxin | 3 | 2002 | 178 | 0.120 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2015 | 171 | 0.120 |
Why?
|
| Phenotype | 9 | 2016 | 16361 | 0.120 |
Why?
|
| Binding Sites | 6 | 2007 | 6111 | 0.120 |
Why?
|
| Interferon Regulatory Factor-7 | 1 | 2013 | 39 | 0.120 |
Why?
|
| Macrophage Activation | 5 | 2010 | 559 | 0.120 |
Why?
|
| Genes | 3 | 1989 | 1893 | 0.120 |
Why?
|
| Fetus | 3 | 2002 | 1880 | 0.120 |
Why?
|
| Angiogenesis Inhibitors | 3 | 2017 | 2037 | 0.110 |
Why?
|
| Peritoneal Fibrosis | 1 | 2013 | 8 | 0.110 |
Why?
|
| Carotid Artery Diseases | 1 | 2000 | 875 | 0.110 |
Why?
|
| Serine | 2 | 2014 | 825 | 0.110 |
Why?
|
| Myeloid Differentiation Factor 88 | 3 | 2015 | 571 | 0.110 |
Why?
|
| Integrin alpha4 | 1 | 2013 | 92 | 0.110 |
Why?
|
| Leukocytes, Mononuclear | 5 | 2002 | 1836 | 0.110 |
Why?
|
| Antiviral Agents | 2 | 2002 | 2984 | 0.110 |
Why?
|
| Gene Knockout Techniques | 2 | 2013 | 807 | 0.110 |
Why?
|
| Bronchoscopy | 3 | 2019 | 861 | 0.110 |
Why?
|
| Listeriosis | 1 | 2014 | 149 | 0.110 |
Why?
|
| Toll-Like Receptor 9 | 2 | 2005 | 211 | 0.110 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2013 | 122 | 0.110 |
Why?
|
| Radiation Chimera | 1 | 2012 | 223 | 0.110 |
Why?
|
| Crosses, Genetic | 3 | 2015 | 791 | 0.110 |
Why?
|
| Injections, Intraperitoneal | 3 | 2002 | 424 | 0.110 |
Why?
|
| Pericytes | 1 | 2015 | 293 | 0.110 |
Why?
|
| Aorta | 2 | 2019 | 2062 | 0.110 |
Why?
|
| Giant Cell Arteritis | 1 | 2016 | 292 | 0.110 |
Why?
|
| Lymphotoxin-alpha | 1 | 2012 | 98 | 0.110 |
Why?
|
| Prostaglandin D2 | 2 | 2004 | 122 | 0.110 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2007 | 2428 | 0.110 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2019 | 811 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 9 | 2016 | 10940 | 0.100 |
Why?
|
| Leukotrienes | 1 | 2013 | 255 | 0.100 |
Why?
|
| Hematopoietic Stem Cells | 5 | 2016 | 3389 | 0.100 |
Why?
|
| Immunoglobulin G | 8 | 2022 | 4561 | 0.100 |
Why?
|
| Listeria monocytogenes | 1 | 2014 | 250 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2017 | 3510 | 0.100 |
Why?
|
| Genes, vif | 1 | 2011 | 17 | 0.100 |
Why?
|
| Transcription Factors | 5 | 2016 | 12209 | 0.100 |
Why?
|
| Apoptosis | 4 | 2013 | 9718 | 0.100 |
Why?
|
| Genes, gag | 1 | 2011 | 61 | 0.100 |
Why?
|
| Cervix Uteri | 2 | 2016 | 590 | 0.100 |
Why?
|
| Immunity, Mucosal | 1 | 2015 | 490 | 0.100 |
Why?
|
| Acute Disease | 6 | 2005 | 7150 | 0.100 |
Why?
|
| Pulmonary Artery | 2 | 2011 | 1911 | 0.100 |
Why?
|
| Kinetics | 6 | 2006 | 6476 | 0.100 |
Why?
|
| Nephritis | 2 | 2013 | 159 | 0.100 |
Why?
|
| Obesity | 3 | 2014 | 12744 | 0.100 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2011 | 133 | 0.100 |
Why?
|
| Lysosomal-Associated Membrane Protein 1 | 1 | 2011 | 26 | 0.100 |
Why?
|
| Thymus Gland | 4 | 2006 | 1266 | 0.100 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 3 | 2003 | 902 | 0.100 |
Why?
|
| Cell Division | 5 | 2004 | 4568 | 0.100 |
Why?
|
| Microscopy | 1 | 2016 | 896 | 0.100 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 2 | 2014 | 343 | 0.100 |
Why?
|
| Reactive Oxygen Species | 4 | 2020 | 2077 | 0.100 |
Why?
|
| Toxoplasmosis, Ocular | 1 | 2011 | 29 | 0.100 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 3547 | 0.100 |
Why?
|
| Kidney Diseases | 2 | 2016 | 2146 | 0.100 |
Why?
|
| Lymph | 2 | 2014 | 80 | 0.100 |
Why?
|
| Blood Proteins | 3 | 2002 | 1125 | 0.100 |
Why?
|
| CD40 Ligand | 1 | 2012 | 526 | 0.100 |
Why?
|
| Graft vs Host Disease | 4 | 2016 | 2958 | 0.100 |
Why?
|
| Chorioretinitis | 1 | 2011 | 43 | 0.100 |
Why?
|
| Receptors, CXCR | 1 | 2011 | 52 | 0.090 |
Why?
|
| Joints | 1 | 2012 | 326 | 0.090 |
Why?
|
| Conserved Sequence | 2 | 2009 | 1202 | 0.090 |
Why?
|
| Syndecan-4 | 1 | 2010 | 44 | 0.090 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2009 | 1503 | 0.090 |
Why?
|
| Chemokine CCL4 | 4 | 1998 | 129 | 0.090 |
Why?
|
| Dermatitis | 1 | 2012 | 199 | 0.090 |
Why?
|
| Synaptotagmin II | 1 | 2010 | 15 | 0.090 |
Why?
|
| Intestinal Mucosa | 2 | 2002 | 3038 | 0.090 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2011 | 1222 | 0.090 |
Why?
|
| Cricetinae | 4 | 2017 | 2475 | 0.090 |
Why?
|
| Administration, Inhalation | 1 | 2013 | 1105 | 0.090 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2017 | 1115 | 0.090 |
Why?
|
| Myofibroblasts | 3 | 2019 | 222 | 0.090 |
Why?
|
| Islets of Langerhans | 2 | 2015 | 1350 | 0.090 |
Why?
|
| Interferons | 2 | 2020 | 706 | 0.090 |
Why?
|
| Sequence Alignment | 3 | 2003 | 2256 | 0.090 |
Why?
|
| Severity of Illness Index | 4 | 2022 | 15526 | 0.090 |
Why?
|
| Bronchial Provocation Tests | 2 | 2019 | 227 | 0.090 |
Why?
|
| Clone Cells | 4 | 2003 | 1692 | 0.090 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 2009 | 0.090 |
Why?
|
| Egg Proteins | 2 | 2006 | 58 | 0.090 |
Why?
|
| Hepatic Stellate Cells | 1 | 2010 | 109 | 0.090 |
Why?
|
| Myocardium | 2 | 2019 | 4775 | 0.090 |
Why?
|
| RANK Ligand | 1 | 2011 | 325 | 0.090 |
Why?
|
| Luminescent Proteins | 1 | 2012 | 853 | 0.090 |
Why?
|
| Trichuris | 1 | 2009 | 32 | 0.090 |
Why?
|
| Aptamers, Nucleotide | 1 | 2011 | 166 | 0.090 |
Why?
|
| Receptors, Leukotriene | 1 | 2010 | 123 | 0.090 |
Why?
|
| Blood Vessels | 1 | 2015 | 1124 | 0.090 |
Why?
|
| Chronic Disease | 4 | 2021 | 9139 | 0.090 |
Why?
|
| Interleukin-6 | 2 | 2016 | 3208 | 0.090 |
Why?
|
| Blotting, Northern | 4 | 2006 | 1581 | 0.080 |
Why?
|
| Interferon-alpha | 1 | 2013 | 895 | 0.080 |
Why?
|
| Membrane Fusion | 1 | 2011 | 276 | 0.080 |
Why?
|
| Interleukin-2 | 2 | 2013 | 1904 | 0.080 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2011 | 246 | 0.080 |
Why?
|
| Coronary Vessels | 2 | 2019 | 3106 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 4 | 2010 | 6170 | 0.080 |
Why?
|
| Plasmids | 3 | 2004 | 2308 | 0.080 |
Why?
|
| Proteins | 6 | 2013 | 6098 | 0.080 |
Why?
|
| Histocompatibility Antigens Class II | 3 | 2024 | 1475 | 0.080 |
Why?
|
| Lung Compliance | 1 | 2009 | 195 | 0.080 |
Why?
|
| Borrelia burgdorferi | 1 | 2010 | 180 | 0.080 |
Why?
|
| Survival Rate | 3 | 2008 | 12786 | 0.080 |
Why?
|
| In Situ Hybridization | 4 | 2000 | 1952 | 0.080 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2010 | 315 | 0.080 |
Why?
|
| Aortic Aneurysm, Abdominal | 2 | 2009 | 1187 | 0.080 |
Why?
|
| Transplantation Chimera | 1 | 2011 | 613 | 0.080 |
Why?
|
| Cryptococcus neoformans | 1 | 2009 | 119 | 0.080 |
Why?
|
| Ectromelia virus | 1 | 2007 | 5 | 0.080 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2011 | 505 | 0.080 |
Why?
|
| Tumor Necrosis Factor-alpha | 6 | 2003 | 4422 | 0.080 |
Why?
|
| Hypersensitivity, Immediate | 2 | 2001 | 337 | 0.080 |
Why?
|
| Aspergillus fumigatus | 2 | 2020 | 150 | 0.080 |
Why?
|
| Vascular Diseases | 2 | 2010 | 1161 | 0.080 |
Why?
|
| Rhinitis, Allergic, Seasonal | 2 | 1999 | 99 | 0.080 |
Why?
|
| Calcium Signaling | 2 | 2011 | 721 | 0.080 |
Why?
|
| Gene Library | 1 | 2011 | 1074 | 0.080 |
Why?
|
| Receptors, HIV | 2 | 1999 | 163 | 0.080 |
Why?
|
| Antigen-Antibody Complex | 3 | 2005 | 517 | 0.080 |
Why?
|
| Acrodermatitis | 1 | 2007 | 18 | 0.080 |
Why?
|
| Erythema Chronicum Migrans | 1 | 2008 | 47 | 0.080 |
Why?
|
| Interleukin-17 | 2 | 2016 | 902 | 0.080 |
Why?
|
| Ultraviolet Rays | 1 | 2012 | 1060 | 0.080 |
Why?
|
| Airway Resistance | 1 | 2009 | 404 | 0.080 |
Why?
|
| Borrelia | 1 | 2008 | 67 | 0.080 |
Why?
|
| Single-Cell Analysis | 1 | 2018 | 2177 | 0.080 |
Why?
|
| Pseudolymphoma | 1 | 2007 | 30 | 0.080 |
Why?
|
| Keratinocytes | 4 | 2016 | 796 | 0.070 |
Why?
|
| Leukemia, Monocytic, Acute | 1 | 1987 | 58 | 0.070 |
Why?
|
| Chitin | 1 | 2007 | 41 | 0.070 |
Why?
|
| GTP-Binding Protein alpha Subunit, Gi2 | 1 | 2007 | 32 | 0.070 |
Why?
|
| Scleroderma, Systemic | 1 | 2011 | 323 | 0.070 |
Why?
|
| Biopsy | 3 | 2016 | 6750 | 0.070 |
Why?
|
| Communicable Diseases | 1 | 2016 | 880 | 0.070 |
Why?
|
| Protein Biosynthesis | 3 | 1998 | 2123 | 0.070 |
Why?
|
| Lymphocyte Culture Test, Mixed | 3 | 2002 | 518 | 0.070 |
Why?
|
| Antibody Formation | 2 | 2009 | 1402 | 0.070 |
Why?
|
| Cell Line, Tumor | 5 | 2017 | 16674 | 0.070 |
Why?
|
| Drug Synergism | 2 | 2002 | 1794 | 0.070 |
Why?
|
| Cell Membrane | 4 | 2006 | 3749 | 0.070 |
Why?
|
| Phosphoproteins | 1 | 2016 | 2440 | 0.070 |
Why?
|
| Wound Healing | 1 | 1998 | 2776 | 0.070 |
Why?
|
| Influenza Vaccines | 1 | 2014 | 738 | 0.070 |
Why?
|
| Kidney | 3 | 2016 | 7185 | 0.070 |
Why?
|
| Immunoblotting | 1 | 2010 | 1683 | 0.070 |
Why?
|
| Rabbits | 3 | 1999 | 4894 | 0.070 |
Why?
|
| Histamine Release | 2 | 1996 | 142 | 0.070 |
Why?
|
| Intestine, Small | 2 | 2004 | 1240 | 0.070 |
Why?
|
| Chemokine CXCL6 | 1 | 2006 | 13 | 0.070 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 2281 | 0.070 |
Why?
|
| RNA Splicing | 2 | 2010 | 907 | 0.070 |
Why?
|
| BCG Vaccine | 2 | 2000 | 369 | 0.070 |
Why?
|
| Hybridization, Genetic | 1 | 2006 | 109 | 0.070 |
Why?
|
| Culture Media, Conditioned | 3 | 2003 | 537 | 0.070 |
Why?
|
| Graft vs Host Reaction | 1 | 2006 | 104 | 0.070 |
Why?
|
| Intubation, Intratracheal | 2 | 2006 | 1365 | 0.070 |
Why?
|
| Phosphorylation | 4 | 2022 | 8436 | 0.070 |
Why?
|
| Precipitin Tests | 2 | 2004 | 829 | 0.070 |
Why?
|
| Bronchoalveolar Lavage | 3 | 2011 | 120 | 0.070 |
Why?
|
| Colon | 2 | 2012 | 1772 | 0.070 |
Why?
|
| Longitudinal Studies | 1 | 2022 | 13980 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 1987 | 374 | 0.070 |
Why?
|
| Phylogeny | 1 | 2013 | 2796 | 0.070 |
Why?
|
| Microscopy, Confocal | 2 | 2005 | 1962 | 0.070 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 1999 | 2839 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 1987 | 417 | 0.070 |
Why?
|
| Erythema | 1 | 2007 | 257 | 0.070 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 3645 | 0.070 |
Why?
|
| Survival | 1 | 2006 | 163 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2011 | 4749 | 0.070 |
Why?
|
| Interferon Type I | 2 | 2015 | 541 | 0.070 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2011 | 688 | 0.070 |
Why?
|
| Aortic Rupture | 1 | 2009 | 312 | 0.070 |
Why?
|
| Toll-Like Receptor 2 | 2 | 2009 | 354 | 0.070 |
Why?
|
| DNA, Protozoan | 1 | 2006 | 237 | 0.070 |
Why?
|
| Cardiotonic Agents | 1 | 2009 | 535 | 0.070 |
Why?
|
| Hyperplasia | 1 | 2009 | 1185 | 0.070 |
Why?
|
| Granuloma | 2 | 2016 | 319 | 0.070 |
Why?
|
| Cycloheximide | 2 | 2000 | 347 | 0.070 |
Why?
|
| Mice, Inbred CBA | 3 | 2011 | 448 | 0.060 |
Why?
|
| Bone Marrow Transplantation | 3 | 2009 | 2764 | 0.060 |
Why?
|
| Fibrosis | 4 | 2016 | 2030 | 0.060 |
Why?
|
| Disease Progression | 4 | 2015 | 13273 | 0.060 |
Why?
|
| West Nile Fever | 1 | 2005 | 78 | 0.060 |
Why?
|
| West Nile virus | 1 | 2005 | 79 | 0.060 |
Why?
|
| Helicobacter felis | 1 | 2004 | 1 | 0.060 |
Why?
|
| HEK293 Cells | 3 | 2019 | 4204 | 0.060 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2005 | 185 | 0.060 |
Why?
|
| Influenza A virus | 1 | 2008 | 457 | 0.060 |
Why?
|
| Food Hypersensitivity | 1 | 2012 | 622 | 0.060 |
Why?
|
| Growth Inhibitors | 2 | 2006 | 385 | 0.060 |
Why?
|
| Peptides | 3 | 2024 | 4406 | 0.060 |
Why?
|
| Viral Proteins | 2 | 2013 | 1899 | 0.060 |
Why?
|
| Receptors, Prostaglandin | 1 | 2004 | 57 | 0.060 |
Why?
|
| Sialoglycoproteins | 1 | 2005 | 318 | 0.060 |
Why?
|
| Klebsiella Infections | 1 | 2005 | 137 | 0.060 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2009 | 1157 | 0.060 |
Why?
|
| Transplantation, Isogeneic | 2 | 2002 | 257 | 0.060 |
Why?
|
| Ribonucleases | 2 | 2006 | 284 | 0.060 |
Why?
|
| Graft Enhancement, Immunologic | 1 | 2004 | 59 | 0.060 |
Why?
|
| Peroxidases | 2 | 2002 | 138 | 0.060 |
Why?
|
| CHO Cells | 2 | 1998 | 1409 | 0.060 |
Why?
|
| Spinal Cord | 2 | 2004 | 1809 | 0.060 |
Why?
|
| Nucleocapsid | 1 | 2024 | 59 | 0.060 |
Why?
|
| Arrestins | 1 | 2004 | 74 | 0.060 |
Why?
|
| Neoplasm Metastasis | 1 | 2014 | 4848 | 0.060 |
Why?
|
| T-Box Domain Proteins | 1 | 2006 | 471 | 0.060 |
Why?
|
| CD4 Lymphocyte Count | 2 | 2007 | 2560 | 0.060 |
Why?
|
| Klebsiella pneumoniae | 1 | 2005 | 249 | 0.060 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1987 | 794 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 4 | 2016 | 5867 | 0.060 |
Why?
|
| Cell Polarity | 2 | 2011 | 645 | 0.060 |
Why?
|
| Simian immunodeficiency virus | 2 | 2019 | 846 | 0.060 |
Why?
|
| Receptors, Fc | 4 | 1989 | 541 | 0.060 |
Why?
|
| Toll-Like Receptor 1 | 1 | 2003 | 48 | 0.060 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2006 | 644 | 0.060 |
Why?
|
| Cell Survival | 3 | 2021 | 5881 | 0.060 |
Why?
|
| Herpes Simplex | 1 | 2007 | 470 | 0.060 |
Why?
|
| Dynamins | 1 | 2004 | 152 | 0.060 |
Why?
|
| Toll-Like Receptor 5 | 1 | 2003 | 39 | 0.060 |
Why?
|
| Purinergic P2 Receptor Antagonists | 1 | 2003 | 71 | 0.060 |
Why?
|
| Granzymes | 2 | 2010 | 271 | 0.060 |
Why?
|
| Gene Expression Profiling | 3 | 2022 | 9440 | 0.060 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2004 | 461 | 0.060 |
Why?
|
| Decidua | 1 | 2003 | 86 | 0.060 |
Why?
|
| Endothelium | 2 | 2004 | 777 | 0.060 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 2003 | 222 | 0.060 |
Why?
|
| Protein Transport | 2 | 2016 | 1988 | 0.060 |
Why?
|
| Binding Sites, Antibody | 1 | 2003 | 349 | 0.060 |
Why?
|
| Phagocytes | 2 | 2022 | 296 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2022 | 1284 | 0.060 |
Why?
|
| Toll-Like Receptor 3 | 1 | 2003 | 90 | 0.050 |
Why?
|
| Immunodominant Epitopes | 1 | 2004 | 267 | 0.050 |
Why?
|
| Dinoprostone | 1 | 2005 | 601 | 0.050 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2011 | 2016 | 0.050 |
Why?
|
| Pneumonia, Bacterial | 1 | 2005 | 316 | 0.050 |
Why?
|
| Macaca mulatta | 2 | 2019 | 2375 | 0.050 |
Why?
|
| Murine hepatitis virus | 1 | 2002 | 20 | 0.050 |
Why?
|
| Analysis of Variance | 3 | 2007 | 6356 | 0.050 |
Why?
|
| Tissue Distribution | 2 | 2017 | 2327 | 0.050 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2017 | 5170 | 0.050 |
Why?
|
| Encephalomyelitis | 1 | 2002 | 34 | 0.050 |
Why?
|
| Coculture Techniques | 2 | 2003 | 1342 | 0.050 |
Why?
|
| Monokines | 2 | 1999 | 79 | 0.050 |
Why?
|
| Macrophages, Alveolar | 3 | 1999 | 407 | 0.050 |
Why?
|
| Superoxides | 1 | 2003 | 387 | 0.050 |
Why?
|
| Adipose Tissue | 1 | 2014 | 3280 | 0.050 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2006 | 1986 | 0.050 |
Why?
|
| Staining and Labeling | 1 | 2006 | 1098 | 0.050 |
Why?
|
| Receptors, Lipoprotein | 1 | 2002 | 81 | 0.050 |
Why?
|
| Cell-Free System | 2 | 1999 | 344 | 0.050 |
Why?
|
| Multigene Family | 2 | 1997 | 1101 | 0.050 |
Why?
|
| Time Factors | 10 | 2014 | 40038 | 0.050 |
Why?
|
| Dermatitis, Contact | 1 | 2002 | 129 | 0.050 |
Why?
|
| NF-kappa B | 2 | 2000 | 2500 | 0.050 |
Why?
|
| Lung Neoplasms | 5 | 2015 | 13112 | 0.050 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2002 | 139 | 0.050 |
Why?
|
| Atherosclerosis | 3 | 2009 | 3445 | 0.050 |
Why?
|
| Clinical Trials as Topic | 1 | 2017 | 7908 | 0.050 |
Why?
|
| Chemokine CCL3 | 2 | 1998 | 84 | 0.050 |
Why?
|
| Antibody Specificity | 2 | 2000 | 1095 | 0.050 |
Why?
|
| Translocation, Genetic | 1 | 1987 | 1420 | 0.050 |
Why?
|
| Eosinophil Peroxidase | 1 | 2000 | 20 | 0.050 |
Why?
|
| Benzylamines | 2 | 2017 | 223 | 0.050 |
Why?
|
| STAT Transcription Factors | 1 | 2022 | 182 | 0.050 |
Why?
|
| Integrins | 2 | 2003 | 846 | 0.050 |
Why?
|
| Cell Size | 1 | 2003 | 641 | 0.050 |
Why?
|
| Graft Survival | 2 | 2002 | 3734 | 0.050 |
Why?
|
| Cell Aggregation | 1 | 2021 | 244 | 0.050 |
Why?
|
| GTP-Binding Proteins | 2 | 2003 | 969 | 0.050 |
Why?
|
| Heterocyclic Compounds | 2 | 2017 | 248 | 0.050 |
Why?
|
| Helicobacter Infections | 1 | 2004 | 388 | 0.050 |
Why?
|
| Adult | 21 | 2019 | 213889 | 0.050 |
Why?
|
| Thioglycolates | 1 | 2000 | 39 | 0.050 |
Why?
|
| Ear | 1 | 2021 | 172 | 0.050 |
Why?
|
| Microbodies | 1 | 2000 | 36 | 0.050 |
Why?
|
| Interleukin-15 | 1 | 2021 | 184 | 0.050 |
Why?
|
| Myelin-Associated Glycoprotein | 1 | 2000 | 113 | 0.050 |
Why?
|
| Regeneration | 1 | 2009 | 1486 | 0.050 |
Why?
|
| Liver Cirrhosis | 1 | 2010 | 1859 | 0.050 |
Why?
|
| Chemokine CXCL13 | 2 | 2012 | 54 | 0.050 |
Why?
|
| Lipids | 1 | 2011 | 3307 | 0.050 |
Why?
|
| von Willebrand Factor | 1 | 2004 | 669 | 0.050 |
Why?
|
| Antineoplastic Agents | 3 | 2017 | 13691 | 0.050 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2004 | 690 | 0.050 |
Why?
|
| Venules | 1 | 2000 | 165 | 0.050 |
Why?
|
| Herpesvirus 4, Human | 1 | 2005 | 1041 | 0.050 |
Why?
|
| Evolution, Molecular | 1 | 2009 | 1940 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 2 | 2004 | 3847 | 0.040 |
Why?
|
| Penicillamine | 1 | 1999 | 59 | 0.040 |
Why?
|
| Caenorhabditis elegans | 1 | 2009 | 1417 | 0.040 |
Why?
|
| Ion Transport | 1 | 2001 | 320 | 0.040 |
Why?
|
| Myelin Proteins | 1 | 2000 | 215 | 0.040 |
Why?
|
| Integrin alphaV | 1 | 2019 | 55 | 0.040 |
Why?
|
| Interleukin-10 | 3 | 2013 | 1200 | 0.040 |
Why?
|
| Aerosols | 1 | 2002 | 623 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2003 | 805 | 0.040 |
Why?
|
| Isoantigens | 1 | 2002 | 567 | 0.040 |
Why?
|
| Glycoproteins | 1 | 2007 | 2266 | 0.040 |
Why?
|
| Demyelinating Diseases | 1 | 2002 | 354 | 0.040 |
Why?
|
| Liver Diseases | 1 | 2008 | 1253 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2015 | 3750 | 0.040 |
Why?
|
| Plaque, Amyloid | 1 | 2003 | 729 | 0.040 |
Why?
|
| Myocarditis | 1 | 2006 | 768 | 0.040 |
Why?
|
| Ethmoid Sinusitis | 1 | 1998 | 25 | 0.040 |
Why?
|
| CpG Islands | 1 | 2003 | 1170 | 0.040 |
Why?
|
| Human Immunodeficiency Virus Proteins | 1 | 2019 | 65 | 0.040 |
Why?
|
| Peptide Fragments | 3 | 2006 | 5096 | 0.040 |
Why?
|
| Guinea Pigs | 2 | 1998 | 1386 | 0.040 |
Why?
|
| nef Gene Products, Human Immunodeficiency Virus | 1 | 2019 | 153 | 0.040 |
Why?
|
| Case-Control Studies | 4 | 2016 | 21733 | 0.040 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 2019 | 159 | 0.040 |
Why?
|
| Cornea | 1 | 2007 | 1521 | 0.040 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 3 | 2012 | 707 | 0.040 |
Why?
|
| Biological Products | 1 | 1987 | 859 | 0.040 |
Why?
|
| p21-Activated Kinases | 1 | 2019 | 128 | 0.040 |
Why?
|
| Goblet Cells | 1 | 2001 | 287 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2006 | 2749 | 0.040 |
Why?
|
| Dendritic Cells, Follicular | 1 | 2018 | 53 | 0.040 |
Why?
|
| Sinusitis | 2 | 1997 | 921 | 0.040 |
Why?
|
| Immunoenzyme Techniques | 2 | 2000 | 1799 | 0.040 |
Why?
|
| Biotinylation | 1 | 2018 | 179 | 0.040 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2002 | 604 | 0.040 |
Why?
|
| Models, Biological | 3 | 2015 | 9582 | 0.040 |
Why?
|
| Central Nervous System Diseases | 1 | 2002 | 518 | 0.040 |
Why?
|
| Colorectal Neoplasms | 1 | 2017 | 6773 | 0.040 |
Why?
|
| Vaccination | 2 | 2014 | 3275 | 0.040 |
Why?
|
| Chemokine CX3CL1 | 1 | 2017 | 59 | 0.040 |
Why?
|
| DNA Restriction Enzymes | 2 | 1987 | 570 | 0.040 |
Why?
|
| Transplantation Conditioning | 1 | 2004 | 1599 | 0.040 |
Why?
|
| Stem Cell Transplantation | 1 | 2006 | 1620 | 0.040 |
Why?
|
| Glycosylation | 2 | 2014 | 1129 | 0.040 |
Why?
|
| Energy Metabolism | 1 | 2008 | 2899 | 0.040 |
Why?
|
| Actins | 2 | 2019 | 2121 | 0.040 |
Why?
|
| Colitis | 1 | 2005 | 1170 | 0.040 |
Why?
|
| Endocytosis | 1 | 2001 | 985 | 0.040 |
Why?
|
| Epitope Mapping | 1 | 2018 | 311 | 0.040 |
Why?
|
| Saphenous Vein | 1 | 2000 | 532 | 0.040 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2013 | 4033 | 0.040 |
Why?
|
| Birefringence | 1 | 2016 | 56 | 0.040 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2017 | 105 | 0.040 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily B | 1 | 2016 | 82 | 0.040 |
Why?
|
| Gene Targeting | 1 | 2000 | 879 | 0.040 |
Why?
|
| Serum Response Factor | 1 | 2016 | 81 | 0.040 |
Why?
|
| Methionine | 1 | 1999 | 590 | 0.040 |
Why?
|
| Collagen | 1 | 2005 | 2681 | 0.040 |
Why?
|
| Cell Count | 3 | 2011 | 1855 | 0.040 |
Why?
|
| Binding, Competitive | 1 | 2018 | 1157 | 0.040 |
Why?
|
| Muscle Relaxation | 1 | 2016 | 142 | 0.040 |
Why?
|
| Cattle | 1 | 2002 | 3917 | 0.040 |
Why?
|
| Apolipoproteins E | 3 | 2007 | 1436 | 0.030 |
Why?
|
| Adenocarcinoma | 2 | 2013 | 6363 | 0.030 |
Why?
|
| Hedgehog Proteins | 1 | 2001 | 784 | 0.030 |
Why?
|
| Nucleic Acid Hybridization | 2 | 1988 | 1374 | 0.030 |
Why?
|
| National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2016 | 62 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell | 3 | 2012 | 2540 | 0.030 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2000 | 581 | 0.030 |
Why?
|
| Protein Conformation | 2 | 2003 | 4009 | 0.030 |
Why?
|
| Rats | 5 | 2012 | 24250 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1997 | 1085 | 0.030 |
Why?
|
| Dermatan Sulfate | 1 | 1995 | 35 | 0.030 |
Why?
|
| Depression, Chemical | 1 | 1995 | 191 | 0.030 |
Why?
|
| Respiratory Mechanics | 1 | 1999 | 686 | 0.030 |
Why?
|
| Viremia | 1 | 2019 | 736 | 0.030 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2016 | 310 | 0.030 |
Why?
|
| Muscles | 1 | 2000 | 1613 | 0.030 |
Why?
|
| E-Selectin | 3 | 2005 | 579 | 0.030 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2004 | 1872 | 0.030 |
Why?
|
| Factor Xa | 1 | 1996 | 162 | 0.030 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 1995 | 226 | 0.030 |
Why?
|
| HLA-B Antigens | 2 | 2012 | 354 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2012 | 9648 | 0.030 |
Why?
|
| Antioxidants | 1 | 2023 | 1658 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2010 | 2503 | 0.030 |
Why?
|
| Mice, Mutant Strains | 3 | 2006 | 1862 | 0.030 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 2015 | 158 | 0.030 |
Why?
|
| Surface Properties | 1 | 2018 | 1168 | 0.030 |
Why?
|
| Heart Failure | 1 | 2019 | 10896 | 0.030 |
Why?
|
| Sus scrofa | 1 | 2016 | 438 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 2 | 2016 | 1613 | 0.030 |
Why?
|
| Interleukin-3 | 1 | 1996 | 444 | 0.030 |
Why?
|
| Immunocompromised Host | 1 | 2020 | 847 | 0.030 |
Why?
|
| Cholesterol | 1 | 2004 | 2922 | 0.030 |
Why?
|
| Escherichia coli | 3 | 1996 | 4216 | 0.030 |
Why?
|
| Cell Separation | 3 | 2010 | 1750 | 0.030 |
Why?
|
| Chimera | 1 | 2016 | 484 | 0.030 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 1999 | 952 | 0.030 |
Why?
|
| Respiratory Function Tests | 1 | 2019 | 1615 | 0.030 |
Why?
|
| Plasmacytoma | 1 | 1995 | 183 | 0.030 |
Why?
|
| Transgenes | 1 | 2018 | 1008 | 0.030 |
Why?
|
| Survival Analysis | 3 | 2015 | 10251 | 0.030 |
Why?
|
| Antigens, Protozoan | 1 | 2016 | 322 | 0.030 |
Why?
|
| Crystallization | 1 | 2015 | 525 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2015 | 291 | 0.030 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2013 | 87 | 0.030 |
Why?
|
| Ticks | 1 | 2013 | 70 | 0.030 |
Why?
|
| Hematopoiesis | 1 | 2003 | 2073 | 0.030 |
Why?
|
| Aortic Diseases | 1 | 2000 | 743 | 0.030 |
Why?
|
| Docosahexaenoic Acids | 1 | 2000 | 877 | 0.030 |
Why?
|
| Tumor Necrosis Factors | 1 | 2013 | 109 | 0.030 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2017 | 567 | 0.030 |
Why?
|
| Collagen Type I | 1 | 2016 | 592 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 2 | 1995 | 3772 | 0.030 |
Why?
|
| Cricetulus | 1 | 1995 | 818 | 0.030 |
Why?
|
| Complement C1q | 1 | 2013 | 93 | 0.030 |
Why?
|
| Arachidonate 5-Lipoxygenase | 1 | 2013 | 144 | 0.030 |
Why?
|
| Sarcoidosis | 1 | 1998 | 506 | 0.030 |
Why?
|
| Neuroblastoma | 1 | 2001 | 1226 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2000 | 1358 | 0.030 |
Why?
|
| Middle Aged | 13 | 2016 | 213241 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 2000 | 1351 | 0.030 |
Why?
|
| Aedes | 1 | 2013 | 99 | 0.030 |
Why?
|
| Vesicular stomatitis Indiana virus | 1 | 2012 | 95 | 0.030 |
Why?
|
| Cartilage | 1 | 2016 | 818 | 0.030 |
Why?
|
| Serine Endopeptidases | 1 | 1998 | 1073 | 0.030 |
Why?
|
| Injections, Subcutaneous | 2 | 2006 | 667 | 0.030 |
Why?
|
| DNA Primers | 1 | 1997 | 2891 | 0.030 |
Why?
|
| Membrane Proteins | 4 | 2009 | 7880 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 708 | 0.030 |
Why?
|
| RNA-Binding Proteins | 2 | 2013 | 1900 | 0.030 |
Why?
|
| Giant Cells | 1 | 2012 | 187 | 0.030 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2015 | 697 | 0.030 |
Why?
|
| Influenza A Virus, H5N1 Subtype | 1 | 2012 | 113 | 0.030 |
Why?
|
| Ventilation-Perfusion Ratio | 1 | 2011 | 116 | 0.030 |
Why?
|
| DNA | 4 | 1997 | 7295 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2003 | 480 | 0.020 |
Why?
|
| Dogs | 1 | 2016 | 3911 | 0.020 |
Why?
|
| Chlorhexidine | 1 | 2013 | 160 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 2016 | 1233 | 0.020 |
Why?
|
| Cyclosporins | 1 | 1991 | 220 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2016 | 1854 | 0.020 |
Why?
|
| Isoxazoles | 1 | 2013 | 216 | 0.020 |
Why?
|
| Transforming Growth Factor alpha | 1 | 1991 | 135 | 0.020 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 1998 | 808 | 0.020 |
Why?
|
| Mitogens | 1 | 2011 | 232 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2003 | 489 | 0.020 |
Why?
|
| Cell Extracts | 1 | 2011 | 138 | 0.020 |
Why?
|
| Administration, Intravaginal | 1 | 2011 | 150 | 0.020 |
Why?
|
| Neoplasm Transplantation | 2 | 2006 | 2085 | 0.020 |
Why?
|
| Carbon Tetrachloride | 1 | 2010 | 64 | 0.020 |
Why?
|
| Rhinitis | 1 | 1998 | 690 | 0.020 |
Why?
|
| Hamartoma | 1 | 2013 | 238 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1997 | 2649 | 0.020 |
Why?
|
| RNA | 3 | 2006 | 2748 | 0.020 |
Why?
|
| Protein Array Analysis | 1 | 2012 | 411 | 0.020 |
Why?
|
| Chemokine CCL7 | 2 | 2001 | 27 | 0.020 |
Why?
|
| Antigens, Surface | 2 | 2009 | 1663 | 0.020 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 1997 | 1366 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 1999 | 2132 | 0.020 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 1993 | 520 | 0.020 |
Why?
|
| Mutation | 3 | 2004 | 29777 | 0.020 |
Why?
|
| Carcinoma, Adenoid Cystic | 1 | 2013 | 252 | 0.020 |
Why?
|
| Cats | 1 | 2011 | 986 | 0.020 |
Why?
|
| Antigens, Viral | 1 | 2014 | 1035 | 0.020 |
Why?
|
| Melanoma | 2 | 2021 | 5508 | 0.020 |
Why?
|
| G1 Phase | 1 | 1991 | 415 | 0.020 |
Why?
|
| Oxadiazoles | 1 | 2010 | 93 | 0.020 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 2010 | 118 | 0.020 |
Why?
|
| Anilides | 1 | 2013 | 409 | 0.020 |
Why?
|
| Remission Induction | 1 | 2015 | 2384 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2016 | 63042 | 0.020 |
Why?
|
| beta-Alanine | 1 | 2010 | 74 | 0.020 |
Why?
|
| Antigens, CD34 | 2 | 2003 | 658 | 0.020 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2011 | 271 | 0.020 |
Why?
|
| Umbilical Veins | 2 | 2000 | 433 | 0.020 |
Why?
|
| Calorimetry | 1 | 2008 | 126 | 0.020 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2013 | 507 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2011 | 813 | 0.020 |
Why?
|
| Immunosorbent Techniques | 1 | 1988 | 184 | 0.020 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2008 | 52 | 0.020 |
Why?
|
| Biphenyl Compounds | 1 | 2013 | 913 | 0.020 |
Why?
|
| Cryptococcosis | 1 | 2009 | 101 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2000 | 2945 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2008 | 180 | 0.020 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2019 | 1832 | 0.020 |
Why?
|
| Drug Eruptions | 1 | 1991 | 297 | 0.020 |
Why?
|
| Galectin 3 | 1 | 2009 | 228 | 0.020 |
Why?
|
| Injections, Intradermal | 1 | 1987 | 117 | 0.020 |
Why?
|
| Positron-Emission Tomography | 2 | 2015 | 6237 | 0.020 |
Why?
|
| Carrier Proteins | 2 | 2013 | 5021 | 0.020 |
Why?
|
| beta-Thromboglobulin | 1 | 1987 | 24 | 0.020 |
Why?
|
| Anti-HIV Agents | 2 | 2003 | 4255 | 0.020 |
Why?
|
| Protozoan Proteins | 1 | 2013 | 825 | 0.020 |
Why?
|
| Cytoskeleton | 1 | 2013 | 1185 | 0.020 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2013 | 518 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2015 | 1691 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2012 | 8300 | 0.020 |
Why?
|
| Austria | 1 | 2008 | 202 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2014 | 2712 | 0.020 |
Why?
|
| Benzamides | 1 | 2013 | 1383 | 0.020 |
Why?
|
| Cancer Vaccines | 2 | 2005 | 1023 | 0.020 |
Why?
|
| Pulmonary Alveoli | 1 | 2010 | 674 | 0.020 |
Why?
|
| Deoxyribonuclease I | 1 | 1987 | 229 | 0.020 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2008 | 769 | 0.020 |
Why?
|
| Hypersensitivity, Delayed | 1 | 1987 | 484 | 0.020 |
Why?
|
| Microcirculation | 1 | 2011 | 1287 | 0.020 |
Why?
|
| Antigens, Differentiation | 1 | 1989 | 927 | 0.020 |
Why?
|
| Genotype | 2 | 2016 | 12944 | 0.020 |
Why?
|
| Echocardiography | 1 | 2019 | 5096 | 0.020 |
Why?
|
| Injections, Intraventricular | 1 | 2006 | 230 | 0.020 |
Why?
|
| Candidiasis | 1 | 2009 | 366 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2006 | 6485 | 0.020 |
Why?
|
| Culicidae | 1 | 2006 | 104 | 0.020 |
Why?
|
| Lymphoma | 1 | 1995 | 1875 | 0.020 |
Why?
|
| Cell Fusion | 1 | 2006 | 297 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2006 | 17439 | 0.020 |
Why?
|
| Mice, Inbred ICR | 1 | 2006 | 352 | 0.020 |
Why?
|
| Nanoparticles | 1 | 2017 | 1898 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2011 | 1374 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2007 | 500 | 0.020 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 1998 | 2248 | 0.020 |
Why?
|
| Fucosyltransferases | 1 | 2005 | 119 | 0.020 |
Why?
|
| Fucose | 1 | 2005 | 126 | 0.020 |
Why?
|
| Thiophenes | 1 | 2010 | 589 | 0.020 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2007 | 471 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2015 | 6487 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 623 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1987 | 1800 | 0.020 |
Why?
|
| RNA, Viral | 1 | 2013 | 2901 | 0.020 |
Why?
|
| Histocompatibility | 1 | 2005 | 330 | 0.020 |
Why?
|
| Estrogen Receptor alpha | 1 | 2008 | 577 | 0.020 |
Why?
|
| Chick Embryo | 1 | 2006 | 983 | 0.020 |
Why?
|
| Cardiovirus Infections | 1 | 2003 | 19 | 0.020 |
Why?
|
| Aorta, Abdominal | 1 | 2007 | 646 | 0.010 |
Why?
|
| Receptors, IgE | 1 | 2006 | 389 | 0.010 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2007 | 637 | 0.010 |
Why?
|
| Coronavirus Infections | 1 | 2002 | 3134 | 0.010 |
Why?
|
| Retroviridae | 1 | 2006 | 913 | 0.010 |
Why?
|
| ADP-ribosyl Cyclase | 1 | 2003 | 38 | 0.010 |
Why?
|
| Interleukin-13 | 1 | 2006 | 389 | 0.010 |
Why?
|
| Blood Coagulation | 1 | 2010 | 1127 | 0.010 |
Why?
|
| Cytoplasm | 1 | 1988 | 1536 | 0.010 |
Why?
|
| Receptors, Purinergic P2Y | 1 | 2003 | 25 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1987 | 1574 | 0.010 |
Why?
|
| Ion Channels | 1 | 2008 | 1056 | 0.010 |
Why?
|
| Aged, 80 and over | 3 | 2016 | 57744 | 0.010 |
Why?
|
| Chemokine CXCL2 | 1 | 2003 | 116 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2019 | 8551 | 0.010 |
Why?
|
| Enterovirus Infections | 1 | 2003 | 72 | 0.010 |
Why?
|
| Mesenteric Arteries | 1 | 2003 | 183 | 0.010 |
Why?
|
| Colony-Forming Units Assay | 1 | 2003 | 355 | 0.010 |
Why?
|
| Ultracentrifugation | 1 | 2003 | 182 | 0.010 |
Why?
|
| Hypoglycemic Agents | 1 | 2015 | 2877 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2016 | 4033 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2013 | 2914 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2013 | 2916 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 1 | 2002 | 116 | 0.010 |
Why?
|
| Peroxiredoxins | 1 | 2002 | 51 | 0.010 |
Why?
|
| Gastritis | 1 | 2004 | 196 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2003 | 644 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 2010 | 1743 | 0.010 |
Why?
|
| Mitochondrial Proteins | 1 | 2008 | 993 | 0.010 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2009 | 852 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 2003 | 8856 | 0.010 |
Why?
|
| Young Adult | 3 | 2015 | 56392 | 0.010 |
Why?
|
| Aged | 6 | 2016 | 163178 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2008 | 2029 | 0.010 |
Why?
|
| Scavenger Receptors, Class B | 1 | 2002 | 82 | 0.010 |
Why?
|
| Scavenger Receptors, Class A | 1 | 2002 | 54 | 0.010 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2010 | 808 | 0.010 |
Why?
|
| Peroxides | 1 | 2002 | 74 | 0.010 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 2001 | 335 | 0.010 |
Why?
|
| Microscopy, Video | 1 | 2002 | 245 | 0.010 |
Why?
|
| Luciferases | 1 | 2003 | 733 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2011 | 5078 | 0.010 |
Why?
|
| Mice, Inbred A | 1 | 2001 | 248 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2005 | 1100 | 0.010 |
Why?
|
| Dimerization | 1 | 2003 | 894 | 0.010 |
Why?
|
| Gastric Mucosa | 1 | 2004 | 599 | 0.010 |
Why?
|
| COS Cells | 1 | 2003 | 1161 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2002 | 743 | 0.010 |
Why?
|
| Intracellular Fluid | 1 | 2001 | 203 | 0.010 |
Why?
|
| Immune Sera | 1 | 2001 | 641 | 0.010 |
Why?
|
| Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2000 | 91 | 0.010 |
Why?
|
| Skull | 1 | 2005 | 812 | 0.010 |
Why?
|
| Diffusion Chambers, Culture | 1 | 2000 | 50 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2015 | 20121 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2006 | 1639 | 0.010 |
Why?
|
| Europe | 1 | 2007 | 3336 | 0.010 |
Why?
|
| HIV Seronegativity | 1 | 2001 | 211 | 0.010 |
Why?
|
| Histocompatibility Testing | 1 | 2002 | 741 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2003 | 4552 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 3917 | 0.010 |
Why?
|
| Probability | 1 | 2006 | 2505 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2001 | 227 | 0.010 |
Why?
|
| Genetic Complementation Test | 1 | 2000 | 561 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2013 | 4152 | 0.010 |
Why?
|
| src-Family Kinases | 1 | 2002 | 551 | 0.010 |
Why?
|
| Receptors, Leukocyte-Adhesion | 1 | 1999 | 53 | 0.010 |
Why?
|
| Vaccines, DNA | 1 | 2001 | 305 | 0.010 |
Why?
|
| RNA Stability | 1 | 2001 | 320 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2004 | 1729 | 0.010 |
Why?
|
| Exudates and Transudates | 1 | 1999 | 172 | 0.010 |
Why?
|
| Oocytes | 1 | 1984 | 1186 | 0.010 |
Why?
|
| Skin Tests | 1 | 2001 | 613 | 0.010 |
Why?
|
| Macrophage-1 Antigen | 1 | 1999 | 290 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2001 | 1422 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2004 | 1841 | 0.010 |
Why?
|
| Administration, Intravesical | 1 | 1998 | 91 | 0.010 |
Why?
|
| Bronchial Neoplasms | 1 | 1999 | 112 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2000 | 771 | 0.010 |
Why?
|
| Heat-Shock Proteins | 1 | 2002 | 820 | 0.010 |
Why?
|
| Reference Values | 1 | 2006 | 4974 | 0.010 |
Why?
|
| Crystallography, X-Ray | 1 | 2003 | 2011 | 0.010 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2001 | 648 | 0.010 |
Why?
|
| Medulloblastoma | 1 | 2003 | 683 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2016 | 5445 | 0.010 |
Why?
|
| Endothelial Growth Factors | 1 | 2000 | 693 | 0.010 |
Why?
|
| Chickens | 1 | 1999 | 864 | 0.010 |
Why?
|
| Immunologic Techniques | 1 | 1998 | 219 | 0.010 |
Why?
|
| Administration, Topical | 1 | 1999 | 689 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1998 | 821 | 0.010 |
Why?
|
| Blood Cell Count | 1 | 1998 | 403 | 0.010 |
Why?
|
| Lymphokines | 1 | 2000 | 948 | 0.010 |
Why?
|
| HIV Core Protein p24 | 1 | 1997 | 256 | 0.010 |
Why?
|
| Leukemia | 1 | 2005 | 1509 | 0.010 |
Why?
|
| Pancreas | 1 | 2003 | 1686 | 0.010 |
Why?
|
| HLA-A2 Antigen | 1 | 1997 | 213 | 0.010 |
Why?
|
| Dactinomycin | 1 | 1997 | 318 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2000 | 1545 | 0.010 |
Why?
|
| Keratins | 2 | 1988 | 515 | 0.010 |
Why?
|
| Urologic Neoplasms | 1 | 2000 | 318 | 0.010 |
Why?
|
| Jejunum | 1 | 1998 | 480 | 0.010 |
Why?
|
| Chromatin | 1 | 1987 | 2931 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2016 | 25032 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1995 | 803 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2003 | 2963 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2003 | 2504 | 0.010 |
Why?
|
| Forced Expiratory Volume | 1 | 1999 | 1740 | 0.010 |
Why?
|
| United States | 2 | 2016 | 69859 | 0.010 |
Why?
|
| Tissue Donors | 1 | 2004 | 2241 | 0.010 |
Why?
|
| Blood Platelets | 1 | 1985 | 2509 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 1999 | 2971 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 1999 | 1224 | 0.010 |
Why?
|
| Hybridomas | 1 | 1994 | 452 | 0.010 |
Why?
|
| Recurrence | 1 | 2004 | 8337 | 0.010 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 1987 | 3524 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2001 | 3421 | 0.010 |
Why?
|
| Alleles | 1 | 2002 | 6934 | 0.010 |
Why?
|
| Adolescent | 2 | 2010 | 85729 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 14714 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2002 | 3622 | 0.010 |
Why?
|
| Transglutaminases | 1 | 1991 | 194 | 0.010 |
Why?
|
| Neoplasms, Experimental | 1 | 1995 | 1272 | 0.010 |
Why?
|
| Regression Analysis | 1 | 1999 | 6457 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2007 | 5752 | 0.010 |
Why?
|
| Insulin | 1 | 2003 | 6584 | 0.010 |
Why?
|
| Glioblastoma | 1 | 2003 | 3480 | 0.000 |
Why?
|
| Linear Models | 1 | 1998 | 5952 | 0.000 |
Why?
|
| Muscle, Skeletal | 1 | 2003 | 4925 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 2004 | 15067 | 0.000 |
Why?
|
| Leishmaniasis | 1 | 1987 | 47 | 0.000 |
Why?
|
| Leprosy | 1 | 1987 | 124 | 0.000 |
Why?
|
| Carcinoma | 1 | 1999 | 2375 | 0.000 |
Why?
|
| Odds Ratio | 1 | 1999 | 9848 | 0.000 |
Why?
|
| Double-Blind Method | 1 | 1999 | 12020 | 0.000 |
Why?
|
| Child | 1 | 2010 | 77637 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2004 | 40545 | 0.000 |
Why?
|
| Xenopus laevis | 1 | 1984 | 956 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2003 | 35409 | 0.000 |
Why?
|